STOCK TITAN

TILRAY BRANDS INC Stock Price, News & Analysis

TLRY Nasdaq

Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.

Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.

Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.

All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.

Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.

Rhea-AI Summary

Tilray Brands (TLRY) has entered into a strategic partnership with HEXO Corp aimed at enhancing operational efficiency and product innovation in the competitive cannabis market. The deal involves Tilray acquiring a US$193 million convertible note from HEXO, which will allow for a significant equity stake in HEXO at a conversion price of C$0.85 per share. The partnership is expected to generate up to US$80 million in cost synergies over two years and will facilitate the sharing of expertise and resources in cannabis product development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.2%
Tags
none
-
Rhea-AI Summary

Tilray Brands (TLRY) reported a net income of $52.5 million and adjusted EBITDA of $10.1 million for Q3 FY2022. Net revenue rose 23% to $152 million, driven by a 32% increase in cannabis revenue and a 64% increase in beverage alcohol revenue. The company achieved $76 million in cost synergies, on track to exceed its $80 million target ahead of schedule. Tilray maintains its leading market share in Canada at 10.2% and holds a 20% share in the German medical cannabis market, positioning itself for future growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
-
Rhea-AI Summary

Manitoba Harvest, a leading hemp foods brand and a subsidiary of Tilray Brands (TLRY), has launched its innovative Hemp+ Matcha and Hemp+ Supergreens powders exclusively at over 300 Whole Foods Market locations across the U.S. The products debuted in April 2022, with each serving providing 6 grams of plant-based protein and 2-3 grams of fiber. This collaboration highlights the increasing popularity of hemp-based foods and the commitment to quality. The powders will remain available after the initial 90-day exclusivity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.13%
Tags
partnership
Rhea-AI Summary

Tilray Brands has launched Solei Bites, its first THC edible, exclusively available at the Société Québécoise du cannabis (SQDC). Each pack contains two bites, formulated with 5 mg of THC, 10 mg of CBD, and includes healthy ingredients like hemp hearts and sunflower seeds. This move expands Solei's product line, aiming to cater to the growing demand in Quebec's legal cannabis market. President Blair MacNeil emphasized the collaboration with SQDC to innovate responsibly in the cannabis sector, enhancing consumer choice.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.64%
Tags
none
-
Rhea-AI Summary

Tilray Brands, a leading cannabis-lifestyle company, will release its third-quarter fiscal 2022 financial results on April 6, 2022, before market open. The conference call is set for 8:30 AM ET on the same day. Shareholders can submit questions via the Say Technologies platform up until 24 hours before the call. Tilray operates globally with over 20 brands across various markets, aiming to enhance well-being through high-quality products. This information comes as part of their ongoing commitment to transparency and shareholder engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.16%
Tags
-
Rhea-AI Summary

Tilray Brands, Inc. has launched its new Renew Moonlight CBN vape pen across Canada, expanding its wellness brand, Solei. This product is designed for nighttime use, featuring a 4:1 THC to CBN ratio, enhanced with citrus and herbal aromas. Brand Manager Danielle Minard emphasizes the product's role in promoting a smoother evening routine. The launch aims to augment Solei's award-winning portfolio of wellness offerings, which already includes popular CBD oils and THC vapes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.85%
Tags
none
Rhea-AI Summary

Tilray Brands has expanded its medical cannabis offerings by launching the first EU GMP medical cannabis oil products in Malta. This move allows patients across Malta to access high-quality cannabis through pharmacies. Denise Faltischek, Chief Strategy Officer, highlighted the growing demand for medical cannabis in the region. With a strong track record in the EU market, Tilray continues to be a significant supplier of medical cannabis products, serving patients in over 20 countries worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none
-
Rhea-AI Summary

Tilray Brands, Inc. (Nasdaq: TLRY) has launched Good Supply Hash Bats™, a new line of hash-infused pre-rolls, which debuted in Ontario in February 2022. The product combines popular strains Jean Guy and Starwalker Kush with hash, offering a higher potency option at 26% THC, exceeding the typical pre-roll THC levels by 5%. The Good Supply brand is well-regarded in Canada and aims to deliver a superior smoking experience. Hash Bats are set for a broader national rollout in April and May 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.52%
Tags
none
-
Rhea-AI Summary

Tilray Brands has announced its intention to acquire HEXO Corp.’s senior secured convertible notes valued at up to US$211 million. This strategic alliance aims to enhance operational efficiencies and product innovation, benefiting both companies. The acquisition is projected to yield approximately C$20 million in interest payments during the first year, adding 4 cents to future earnings per share. Furthermore, both companies expect to realize up to C$50 million in shared cost synergies over the next two years, with Tilray nominating a member to HEXO’s Board upon closure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.03%
Tags
none
Rhea-AI Summary

Manitoba Harvest is set to showcase its innovative Hemp food products at Natural Products Expo West from March 10-12, 2022, in Anaheim, CA. The brand will unveil a new lineup that includes Hemp Protein powders blended with Matcha and Kale, as well as convenient formats like Ground Hemp Seeds. These products aim to enhance consumer wellness by leveraging hemp's rich protein and omega content. With a history since 1998, Manitoba Harvest, a subsidiary of Tilray Brands (NASDAQ: TLRY), emphasizes quality and sustainability in their hemp-based offerings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none

FAQ

What is the current stock price of TILRAY BRANDS (TLRY)?

The current stock price of TILRAY BRANDS (TLRY) is $1.37 as of August 27, 2025.

What is the market cap of TILRAY BRANDS (TLRY)?

The market cap of TILRAY BRANDS (TLRY) is approximately 1.5B.
TILRAY BRANDS INC

Nasdaq:TLRY

TLRY Rankings

TLRY Stock Data

1.53B
1.09B
0.82%
10.02%
16.95%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
Canada
NEW YORK